Literature DB >> 26974992

Prescribing opioids in primary care: Safely starting, monitoring, and stopping.

Daniel G Tobin1,2, Rebecca Andrews3,4, William C Becker5,6.   

Abstract

Chronic noncancer pain is common and often managed in the outpatient setting with chronic opioid therapy, even though the efficacy of this approach is uncertain and adverse effects are common. Some patients report meaningful benefit from opioids, but prescription drug abuse has reached epidemic proportions, and many suffer harm from opioid misuse, abuse, and diversion. Primary care providers and their care teams often struggle to balance these risks and benefits with little outside support. The authors review common challenges when starting, monitoring, and discontinuing opioids, and offer strategies for risk-reduction and patient communication.
Copyright © 2016 Cleveland Clinic.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26974992     DOI: 10.3949/ccjm.83a.15034

Source DB:  PubMed          Journal:  Cleve Clin J Med        ISSN: 0891-1150            Impact factor:   2.321


  3 in total

Review 1.  Opioids for chronic pain management in patients with dialysis-dependent kidney failure.

Authors:  William C Becker; Michael J Fischer; Daniel G Tobin; Mark B Lockwood; Paul L Kimmel; Laura M Dember; Nwamaka D Eneanya; Manisha Jhamb; Thomas D Nolin
Journal:  Nat Rev Nephrol       Date:  2021-10-07       Impact factor: 28.314

2.  Associations Between Physical Pain, Pain Management, and Frequency of Nonmedical Prescription Opioid Use Among Young Adults: A Sex-specific Analysis.

Authors:  Tristan I Evans; Elliott J Liebling; Traci C Green; Scott E Hadland; Melissa A Clark; Brandon D L Marshall
Journal:  J Addict Med       Date:  2017 Jul/Aug       Impact factor: 3.702

3.  Giving Credence to the Experience of X-Linked Hypophosphatemia in Adulthood: An Interprofessional Mixed-Methods Study.

Authors:  Melissa Hughes; Carolyn Macica; Catherine Meriano; Maya Doyle
Journal:  J Patient Cent Res Rev       Date:  2020-04-27
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.